HAL
50
4
TXT
60
4
ZBH
53
-3
DIS
68
3
CNP
65
2
ETN
78
-2
CAG
36
-10
WHR
61
2
ADM
30
2
FFIV
67
-3
K
62
2
NWL
57
3
CMS
67
2
CMCSA
59
2
LEN
59
4
BEN
55
2
EA
52
3
MAR
65
2
MU
48
-4
WDC
59
-2
HAL
50
4
TXT
60
4
ZBH
53
-3
DIS
68
3
CNP
65
2
ETN
78
-2
CAG
36
-10
WHR
61
2
ADM
30
2
FFIV
67
-3
K
62
2
NWL
57
3
CMS
67
2
CMCSA
59
2
LEN
59
4
BEN
55
2
EA
52
3
MAR
65
2
MU
48
-4
WDC
59
-2
Financhill
Back

Riley Exploration Permian Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
60

REPX
Riley Exploration Permian

Last Price:
26.96
Seasonality Move:
-3.51%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Buy
60
Riley Exploration Permian (REPX) is a Buy

Is Riley Exploration Permian a Buy, Sell or Hold?

  • The current Riley Exploration Permian [REPX] share price is $27.02. The Score for REPX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • REPX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REPX Stock Price Chart

What is Riley Exploration Permian's stock price today?

  • The Riley Exploration Permian share price today is $27.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REPX is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

REPX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 50.12 Buy
Chaikin Money Flow: 30636 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.87 - 28.19) Sell
Bollinger Bands (100): (25.98 - 28.78) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

REPX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.26 Sell
20-day SMA: 26.65 Buy
50-day SMA: 27.19 Sell
200-day SMA: 26.77 Buy
8-day EMA: 27.05 Sell
20-day EMA: 26.97 Buy
50-day EMA: 27.16 Sell
200-day EMA: 27.73 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Riley Exploration Permian Earnings Growth & REPX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.45 per share, an increase this year of $0.71 per share, and an increase next year of $1.11 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Riley Exploration Permian Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):